Is genesispharma.com Safe? Security Analysis for GENESIS Pharma
https://genesispharma.comCheck if genesispharma.com is a scam or legitimate. Free security scan and reviews.
Above Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for genesispharma.com
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
GENESIS Pharma is a well-established biopharmaceutical company specializing in the commercialization of innovative pharmaceutical products targeting serious and rare diseases across Central and Eastern Europe. The company positions itself as a trusted regional partner for leading global biopharmaceutical firms, with a portfolio focused on chronic and rare disease treatments. Their business model centers on strategic partnerships, pharmacovigilance, and logistics services to ensure innovative therapies reach patients effectively. The website reflects a mature digital presence with professional design, clear navigation, and mobile optimization, supporting their market position as a regional leader. Technically, the website employs modern JavaScript libraries such as Swiper.js for interactive content and includes a cookie consent mechanism indicating awareness of privacy compliance. The site is responsive and well-structured, though explicit privacy and terms of service pages are not found, which is a compliance gap. Security posture is good with HTTPS enforced and secure form inputs, but lacks some advanced security headers and incident response contact details. Overall, the security posture is solid but could be improved by publishing comprehensive privacy policies, terms of service, and vulnerability disclosure information. The absence of WHOIS data for the domain is a concern that slightly reduces trustworthiness, though the website content and partner affiliations strongly indicate legitimacy. Strategic recommendations include enhancing transparency on privacy and security policies and improving domain registration visibility to bolster trust.
Detected Technologies
5 urgent findings need attention
5 high
Keep genesispharma.com under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
7 findings
30/100
GDPR Compliance
2 findings
83/100
NIS2 Compliance
6 findings
47/100
Email Security
4 findings
75/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
GENESIS Pharma operates in the healthcare sector with a focus on biopharmaceutical commercialization in Central and Eastern Europe. The company leverages nearly three decades of experience and a broad partner network of leading global biopharmaceutical companies. Their competitive advantage lies in regional expertise, a comprehensive portfolio of orphan and chronic disease therapies, and a strong logistics and pharmacovigilance infrastructure. The business model is partnership-driven, facilitating access to innovative medicines for underserved markets. Growth indicators include multiple subsidiaries across the region and a clear commitment to innovation and quality. The company’s digital presence supports its strategic positioning but could benefit from enhanced compliance transparency.
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a mature security posture with HTTPS enforced and secure handling of user inputs in forms. The presence of a cookie consent mechanism aligns with privacy best practices. However, the absence of explicit privacy and terms of service pages, lack of published incident response contacts, and missing security headers such as Content-Security-Policy and X-Frame-Options represent areas for improvement. No vulnerabilities or exposed sensitive data were detected in the HTML content. The missing WHOIS data for the domain is a potential red flag that should be investigated further. Overall, the security maturity is good but not comprehensive.
Strategic Recommendations
Priority Actions for Security Improvement
Publish a comprehensive privacy policy page clearly accessible from the homepage.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
GENESIS Pharma
Leading biopharmaceutical company specializing in the commercialization of innovative pharmaceutical products for serious and rare diseases in Central and Eastern Europe. Partner of choice for some of the world's leading biopharmaceutical companies.
excellent
consistent
Technical Stack
moderate
excellent
good
good
Security Assessment
- HTTPS enforced
- Cookie consent mechanism implemented
- No exposed sensitive data in HTML
- Secure form with minimum input validation (search form)
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is fully accessible with rich content and navigation
Get this report delivered to your inbox
Receive a summary of the genesispharma.com security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing X-Frame-Options header
HIGHPrevents clickjacking attacks
Missing X-Content-Type-Options header
MEDIUMPrevents MIME type sniffing
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Need this report as a PDF?
Download the complete genesispharma.com security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
DMARC not enforcing
MEDIUMDMARC policy is set to "none"
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
DKIM Selectors Found
DMARC Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 39 days
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
Domain Delete Lock Not Enabled
LOWDomain can be deleted without additional verification
DMARC Policy Set to None
LOWDMARC is configured but not enforcing any policy
Domain Registration Details
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does genesispharma.com compare?
See how genesispharma.com stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the genesispharma.com report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the genesispharma.com report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about genesispharma.com
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published